NewcelX Ltd.
Kloten, Switzerland ยท Biotechnology
NewcelX Ltd. is a biotechnology company based in Kloten, Switzerland. In a Form D filed with the SEC on August 24, 2026, it reported raising $2,940,234 from 5 investors as part of an offering of up to $2,940,234. The first sale in the offering took place on July 3, 2026.
- Amount raised
- $2,940,234
- Offering size
- $2,940,234
- Investors so far
- 5
- First sale
- July 3, 2026
- Securities offered
- Equity, Options or warrants, Securities issuable on exercise or conversion, Other
- Exemption claimed
- Rule 506(b)
- Industry
- Biotechnology
- Headquarters
- Kloten, Switzerland
- Incorporated
- Switzerland
- Entity type
- Other
Filings
| Filed | Form | Raised | Offering size | Investors | Source |
|---|---|---|---|---|---|
| D (new notice) | $2,940,234 | $2,940,234 | 5 | SEC filing |
Figures come from the company's own filing with the SEC and are shown as reported. How to read a Form D.
Other health care raises
| Company | Location | Sector | Raised | Target | Filed |
|---|---|---|---|---|---|
| Curadel Surgical Innovations, Inc. | Bonita Springs, FL | Health Care | $49.8M | $57.5M | |
| Axelyf, Inc. | Chestnut Hill, MA | Health Care | $2.6M | $2.7M | |
| iPill Inc. | Rowland Heights, CA | Health Care | $1.3M | $1.5M | |
| Dvant Pharma, Inc. | Superior Township, MI | Health Care | $1.2M | $3.1M | |
| FibroBiologics, Inc. | Houston, TX | Health Care | $1.2M | $1.2M | |
| Vimy Pharmaceuticals Inc. | Toronto, Ontario, Canada | Health Care | $1M | $1M |